leisure time -WSS

leisure time

author：comprehensive 2025-09-27 12:54:43 - browse：89714

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Scientists at the Food and Drug Administration have two big questions about Eli Lilly’s experimental Alzheimer’s drug donanemab ahead of a panel of outside experts that it is convening on Monday:

Should the patients who receive the medicine be limited based on PET scans of a protein called tau that Eli Lilly used as a key criteria for trying to determine whether they should receive the drug? That could reduce usage of the medicine by adding a barrier to its use.

And how do the potential risks of using the drug compare to its benefits? The FDA points to one analysis, admittedly with missing data, that could indicate patients who receive the drug have a higher risk of dying.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： H5N1 communication has been strictly for the birds

WSS

Why the advice to take all your antibiotics may be wrong

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Elevance, private equity launch primary care company

Google says AlphaFold 3 can map a vast universe of biomolecules

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

As demand for Covid shots wanes, Moderna seeks its next success

H5N1 communication has been strictly for the birds

After affirmative action ruling, medical educators look to 'holistic review'

Dairy farmers resist CDC push for PPE against bird flu virus

Heart attack and stroke risk calculators need revising

Telehealth startups turn to complex chronic diseases

How to save PrEP access — and even expand it

H5N1 bird flu: what we're starting to learn about infection in cows

New air purifier tech could be key to improving indoor air quality

Steward Health Care files for bankruptcy

leisure time

Researchers on aging grapple with how to calculate biological age

H5N1 bird flu: what we're starting to learn about infection in cows

'The View' co

Florida babysitter arrested over hot car death, authorities say

Brain worms: The science behind RFK Jr.'s parasitic infection

Hey, doctors: Don't be no

entertainment

hotspot

focus

focus